A randomized phase III study of maintenance therapy with TS-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus TS-1 for advanced or relapsed squamous cell carcinoma of the lung
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Jul 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Lung cancer; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 04 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Oct 2014 According to UMIN, inclusion criteria has been modified to include patients with postoperative recurrence of squamous cell carcinoma of the lung.
- 09 Apr 2013 New trial record